Back to News
Market Impact: 0.25
Sino Biopharmaceutical Limited - Depositary Receipt Consensus Price Target Increased by 54.99% to $25.72
Source: Nasdaq
Analyst EstimatesAnalyst Insights
The average one-year price target for Sino Biopharmaceutical Limited’s depositary receipt (OTCPK:SBHMY) was revised to $25.72 per share, up 54.99% from the prior estimate of $16.59 dated February 3, 2026. The article excerpt does not provide further details about the estimate aggregation or any market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
More News
- Biotech stocks are surging. How investors can play the new drug innovation boom
- Goldman says these top tech stocks have plenty of upside ahead of earnings
- ProPetro’s 49% decline: how Fair Value spotted the warning signs
- Persistent Oil Prices Threaten Inflation Outlook
- Could France’s debt crisis spread across Europe?
- Japan Post Holdings sells $1.37M in Aflac stock